Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 10Recruiting 2Active not recruiting 2Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Neoplasm Metastasis 1Adolescent Behavior 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Aging × Clear all
NCT07011862 2026-04-24

COBRA: Cancer, Older Adults, Balance and Resistance Activities

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
38 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06824441 2026-03-12

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

Stanford University

Phase NA Active not recruiting
83 enrolled

Adolescent Behavior, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡